Evidence map›Paper›PMID 29375537›Full record

ArticleFrontiers in microbiology2017

Overcoming Antimicrobial Resistance in Bacteria Using Bioactive Magnetic Nanoparticles and Pulsed Electromagnetic Fields.

Vitalij Novickij, Ramunė Stanevičienė, Iglė Vepštaitė-Monstavičė, Rūta Gruškienė, Tatjana Krivorotova, Jolanta Sereikaitė, Jurij Novickij, Elena Servienė

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Nanomaterials as Promising Alternative in the Infection Treatment.International journal of molecular sciences · 2019
    Review
  14. Article
  15. Inactivation ofFrontiers in microbiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vitalij NovickijInstitute of High Magnetic Fields, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Ramunė StanevičienėLaboratory of Genetics, Institute of Botany, Nature Research Centre, Vilnius, Lithuania.
Iglė Vepštaitė-MonstavičėLaboratory of Genetics, Institute of Botany, Nature Research Centre, Vilnius, Lithuania.
Rūta GruškienėDepartment of Chemistry and Bioengineering, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Tatjana KrivorotovaInstitute of Chemistry, Vilnius University, Vilnius, Lithuania.
Jolanta SereikaitėDepartment of Chemistry and Bioengineering, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Jurij NovickijInstitute of High Magnetic Fields, Vilnius Gediminas Technical University, Vilnius, Lithuania.
Elena ServienėLaboratory of Genetics, Institute of Botany, Nature Research Centre, Vilnius, Lithuania.
Vilnius Gediminas Technical University · LTNature Research Centre · LTVilnius University · LT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nisin is a known bacteriocin, which exhibits a wide spectrum of antimicrobial activity, while commonly being inefficient against Gram-negative bacteria. In this work, we present a proof of concept of novel antimicrobial methodology using targeted magnetic nisin-loaded nano-carriers [iron oxide nanoparticles (NPs) (11-13 nm) capped with citric, ascorbic, and gallic acids], which are activated by high pulsed electric and electromagnetic fields allowing to overcome the nisin-resistance of bacteria. As a cell model the Gram-positive bacteria

Indexed as

antimicrobial resistancebacteria inactivationB. subtilisE. coliiron oxide nanoparticlesnisin

Identifiers

PMID29375537
PMCPMC5767227
OpenAlexW2782593105

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.